ClinicalTrials.gg
CompletedNCT03711643HYPNOTICUpdated Dec 23, 2025

Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging

An interventional study of Periprostatic nerve block and hypnosis mask in Prostatic Diseases, sponsored by University Hospital, Lille. Completed at 1 site in France. Open to male participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by University Hospital, Lille · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
50 Years to 75 Years
Sex
Male
01

Study summary

The prostatic biopsies echo-guided are a painful and stressful. The purpose is to test a new medical device created recently, " Hypnos-Pro ", wich uses connected technologies. This connected device is a mask with diodes coupled with an audio headset and a touch pad. This connected mask is an another option to induce an hypnotic state for our patients. the objective is to value hypnotic mask effectiveness, to reduce the level pain and anxiety for the patients who benefit a prostatic biopsies echo-guided with local anesthesia.

02

Conditions studied

  • Prostatic Diseases

Browse trials for

Keywords

  • prostatic biopsies echo-guided
  • Pain measurement
  • Anxiety assessment
03

In context

Prostatic Diseases

84 studies on the registry are indexed under Prostatic Diseases; 19 are open to participants now.

This study's enrollment of 88 is above the median of 77 across 66 interventional studies indexed under Prostatic Diseases.

Browse Prostatic Diseases studies →

Lead sponsor

University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient eligible for prostate
  • Having accepted and signed the consent, for performing a prostate biopsy ultrasound examination
  • No to the gesture
  • Supporting the left lateral decubitus

Exclusion criteria

Exclusion Criteria:

  • Patient isolation contact / droplets
  • Patient with hearing and / or epilepticus and / or dementia and / or having a history of stroke and / or allergic to lidocaine
  • Person unable to consent, or benefiting from a system of legal protection (tutelage / curatorship).
  • Patients with epileptic seizures.
  • Patients with known allergies to plastics and other resins that may develop allergic contact dermatitis.
  • Patients who are hypersensitive to radio frequency.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
88 participants (actual)

Study arms

  • Experimental
    Optimizing pain management

    An experimental group receive a standard pain management and benefit the hypnotic mask (Hypnos pro).

    Procedure: Periprostatic nerve block · Device: hypnosis mask

  • Active comparator
    standard pain management

    Procedure: Periprostatic nerve block

Interventions

  • ProcedurePeriprostatic nerve block

    4 injections of 2 cc of lidocaine for a Periprostatic nerve block

  • Devicehypnosis mask

    The mask HYPNOS pro stimulates the imagination of the user by means of 6 diodes among 3 by eye. Just before the introduction of ultrasound probe, the patient put the hypnotic mask and choose a session.Twenty minutes after the removal of the probe, an healthworker assess the painful patient with the visual analogue scale VAS, after this the patient fulfill the STATE- TRAIT Anxiety Inventory (STAI) form Y-A.

06

What researchers measure

Primary outcomes

  1. Visual analogic Scale

    Measure the pain in the scale from 0 to 10

    Time frame: at 20 minutes after the removal of the probe

Secondary outcomes

  1. State-Trait Anxiety Inventory ou STAI forme Y-A

    Time frame: Baseline, at 20 minutes after the removal of the probe

  2. Percentage of positive response of satisfaction of the patient

    The question is: Would you do prostate biopsy punctures under the same conditions in a month? (Yes: effective method, No: ineffective method).

    Time frame: at 20 minutes after the removal of the probe

  3. Percentage of positive response of satisfaction of the operator

    The question is: In your opinion, has the gesture been made optimally? (Yes/ No).

    Time frame: at 20 minutes after the removal of the probe

07

Study locations

1 site
  • Hôpital Claude Huriez, CHU
    Lille, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03711643
Responsible party
Sponsor
First posted
Oct 18, 2018
Start date
May 7, 2019
Primary completion
Oct 26, 2021
Completion
Oct 26, 2021
Last update
Dec 23, 2025

Study contacts

Philippe Puech, MD,PhD
principal investigator · University Hospital, Lille

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion